Inventor · disambiguated record
Jonathan Ma Levy
Also filed as: LEVY JONATHAN · LEVY JONATHAN M · LEVY JONATHAN MA
3 granted patents·10 pending applications·84 citations·filing 2017–2024
75Inventor score
Top patents by PatentIndex Score
13 records- 0195US12031126B2Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequenceBROAD INST INC·Filed 2023·Granted Jul 9, 2024·18 cites·41 claims
- 0295US11912985B2Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequenceBROAD INST INC·Filed 2022·Granted Feb 27, 2024·23 cites·29 claims
- 0393US11306324B2AAV delivery of nucleobase editorsHARVARD COLLEGE·Filed 2017·Granted Apr 19, 2022·43 cites·36 claims
- 0482US2025215418A1Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequenceBROAD INST INC·Filed 2024·Application pending·0 cites
- 0570US2025064981A1Aav vectors encoding base editors and uses thereofBROAD INST INC·Filed 2024·Application pending·0 cites
- 0665US2022213507A1Aav delivery of nucleobase editorsHARVARD COLLEGE·Filed 2022·Application pending·0 cites
- 0764US2024067940A1Methods and compositions for editing nucleotide sequencesPRIME MEDICINE INC·Filed 2023·Application pending·0 cites
- 0861US2024229038A1Genome editing compositions and methods for treatment of wilson's diseasePRIME MEDICINE INC·Filed 2024·Application pending·0 cites
- 0959US2025179483A1Genome editing compositions and methods for treatment of glycogen storage disease type 1bPRIME MEDICINE INC·Filed 2022·Application pending·0 cites
- 1057US2024167026A1Genome editing compositions and methods for treatment of wilson's diseasePRIME MEDICINE INC·Filed 2023·Application pending·0 cites
- 1152US2023159913A1Targeted base editing of the ush2a geneBROAD INST INC·Filed 2021·Application pending·0 cites
- 1251US2022249697A1Aav delivery of nucleobase editorsBROAD INST INC·Filed 2020·Application pending·0 cites
- 1346US2024051969A1Ror-gamma inhibitors for the treatment of ror-gamma-dependent cancerDIACCURATE·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →